About Engin Sciences
Engin Sciences is a private company based in New York City, New York. It has reported $5,216,012 raised in four offerings on Form D since September 2022. Its chief executive is Sloane Barbour III.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 16, 2026 | Feb 2, 2026 | $2,269,222of $3.5M target | 4 | $567K | EquityRule 506(b) | Form D ↗ |
| Mar 21, 2025 | Mar 28, 2025 | $700,000of $1.0M target | 4 | $175K | Debt, OptionsRule 506(b) | Form D ↗ |
| Jun 14, 2024 | Jun 20, 2024 | $650,000of $1.0M target | 4 | $162K | Debt, OptionsRule 506(b) | Form D ↗ |
| Aug 25, 2022 | Sep 7, 2022 | $1,596,790of $3.5M target | 6 | $266K | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $5,216,012 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Engin Sciences's Form D filed Feb 2, 2026.
DR
David Rosenthal
Director
SI
Sloane Barbour III
CEO and director
PP
Palle Pedersen
Director
AA
Andres Azcarraga
Director
PF
Peter Flint
Director
Earlier filings also listed John Farrell (director, last listed Mar 2025) and Michael Henderson-Cohen (director, last listed Sep 2022).